Novartis Statistics and Revenue Totals (2023)
Last Updated on: May 25th, 2023
Here are a few of the most interesting Novartis statistics I was able to dig up including Novartis revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Novartis Facts
- Website: Official Website
- Year Founded: 1996
- Headquarters: Basel, Switzerland
- Founder(s): Johann Rudolf, Alexander Clavel
- Current Chief Executive: Vasant Narasimhan
- Subsidiaries / Brands: Ciba Vision, Chiron Corp, Sandoz
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world. (source)
Novartis Statistics
Novartis Revenue Totals
Novartis annual net sales:
- FY 2022: $50.545 billion
- FY 2021: $51.626 billion
- FY 2020: $48.659 billion
- FY 2019: $47.445 billion
- FY 2018: $44.751 billion
- FY 2017: $42.338 billion
- FY 2016: $41.975 billion
- FY 2015: $42.641 billion
Novartis annual net income:
- FY 2022: $6.955 billion
- FY 2021: $24.018 billion
- FY 2020: $8.071 billion
- FY 2019: $11.737 billion
- FY 2018: $12.614 billion
- FY 2017: $7.703 billion
- FY 2016: $6.698 billion
- FY 2015: $17.794 billion
Additional Novartis Statistics
Number of countries where Novartis products are available in:
Last updated 9/25/18
Please note that some of these numbers are easier to find than others. A few of these Novartis statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags: